Both the Entamoeba histolytica lectin, a virulence factor for the causative agent of amebiasis, and the mammalian hepatic lectin bind to N-acetylgalactosamine (GalNAc) and galactose (Gal) nonreducing termini on oligosaccharides, with preference for GalNAc. Polyvalent GalNAc-derivatized neoglycoproteins have >1000-fold enhanced binding affinity for both lectins (Adler,P., Wood,S.J., Lee,Y.C., Lee,R.T., Petri,W.A.,Jr. and Schnaar,R.L.,1995, J. Biol. Chem., 270, 5164-5171). Substructural specificity studies revealed that the 3-OH and 4-OH groups of GalNAc were required for binding to both lectins, whereas only the E.histolytica lectin required the 6-OH group. Whereas GalNAc binds with 4-fold lower affinity to the E.histolytica lectin than to the mammalian hepatic lectin, galactosamine and N-benzoyl galactosamine bind with higher affinity to the E.histolytica lectin. Therefore, a synthetic scheme for converting polyamine carriers to poly-N-acyl galactosamine derivatives (linked through the galactosamine primary amino group) was developed to test whether such ligands would bind the E.histolytica lectin with high specificity and high affinity. Contrary to expectations, polyvalent derivatives including GalN 6 lys 5 , GalN 4 desmosine, GalN 4 Starburst TM dendrimer, and GalN 8 Starburst TM dendrimer demonstrated highly enhanced binding to the mammalian hepatic lectin but little or no enhancement of binding to the E.histolytica lectin. We propose that the mammalian hepatic lectin binds with greatest affinity to GalNAc "miniclusters," which mimic branched termini of N-linked oligosaccharides, whereas the E.histolytica lectin binds most effectively to "maxiclusters," which may mimic more widely spaced GalNAc residues on intestinal mucins.
Introduction
It is estimated that 500 million individuals are infected with E.histolytica worldwide, resulting in 40-50 million cases of colitis or abscess and 40-100 thousand deaths annually (Walsh, 1986) . The Entamoeba histolytica adherence lectin, a virulence factor for this causative agent of amebiasis, binds to nonreducing terminal GalNAc and Gal residues on glycoconjugates (McCoy et al., 1994; Adler et al., 1995) . Since E.histolytica infection requires the Gal/GalNAc lectin, it is reasonable to envision therapeutic strategies which target the lectin. However, such strategies must account for the similarity in specificity between the E.histolytica lectin and the mammalian hepatic lectin, which rapidly clears serum-borne Gal or GalNAc terminated saccharides (Ashwell and Morell, 1974) . The mammalian hepatic lectin is a thoroughly studied carbohydrate binding protein which shares no structural similarity with the E.histolytica lectin, but which also binds to GalNAc and Gal nonreducing termini on glycoconjugates (Ashwell and Harford, 1982; Spiess, 1990) . We reported previously that polyvalent N-acetylgalactosaminides bind with high affinity to both the E.histolytica and rat hepatic Gal/GalNAc lectins (Adler et al., 1995) . E.histolytica lectin binding was carbohydrate specific, in that neoglycoproteins bearing GalNAc or Gal residues bound with high affinity, whereas those bearing Glc, GlcNAc, Man, or Fuc residues failed to bind. Furthermore, the E.histolytica lectin bound to GalNAc 39 BSA with >100-fold higher affinity than to Gal 40 BSA. Here, we compare the fine-structural specificities of the E.histolytica and rat hepatic lectins for GalNAc residues, and report their relative affinities for various polyvalent N-acylgalactosamine cluster ligands.
Results

Effects of GalNAc hydroxyl group and N-acyl group modifications on rat hepatic and E.histolytica lectin binding
Synthetic derivatives were used to compare the role of each hydroxyl and the N-acyl moiety of GalNAc in binding to the E.histolytica and rat hepatic lectins. Various derivatives were tested, each at a series of concentrations up to 2.5 mM, for their ability to inhibit membrane binding of 125 I-GalNAc 39 BSA, a high-affinity ligand for both the rat hepatic (K D = 0.6 nM) and E.histolytica (K D = 5 nM) lectins (Adler et al., 1995) .
Deoxy-GalNAc derivatives revealed a distinct difference in specificity between the two lectins ( Figure 1 , Table I ). The rat hepatic lectin, as previously reported (Wong et al., 1987; Ichikawa et al., 1990; Lee et al., 1991) , required the 3-OH and 4-OH for inhibition, whereas the 6-OH was not required. In contrast, each of the hydroxyl groups, including the 6-OH, was required for inhibition of the E.histolytica lectin. Data using 4-F and 6-OCH 3 N-acetylgalactosaminides (Wong et al., 1987) supported these findings, in that the 4-F derivative failed to inhibit either lectin, whereas the 6-OCH 3 derivative inhibited the rat hepatic lectin only.
Replacement of the N-acetyl group with the bulkier N-benzoyl group resulted in a marked (9-fold) decrease in affinity for the rat hepatic lectin, consistent with previous reports (Wong et al., 1987; Lee et al., 1991) . In contrast N-benzoyl galactosamine had a 2-fold higher affinity than GalNAc for the E.histolytica lectin (Figure 2 , Table I ). The free amino sugar, GalN, was 1000-fold less potent than GalNAc in binding the rat hepatic lectin, whereas binding of GalN to the E.histolytica lectin was reduced only by 8-fold compared to GalNAc (Figure 2 , Table I ), indicating greater tolerance of changes at the N-acyl position for the E.histolytica lectin. Fig. 1 . Inhibition of 125 I-GalNAc 39 BSA binding to E.histolytica and rat hepatic lectins by GalNAc and GalNAc glycoside derivatives. Inhibition of radioligand binding was determined as described in Materials and methods using 0.8 nM 125 I-GalNAc 39 BSA and 5-10 µg membrane protein for the rat hepatic lectin (solid bars), and 0.7-1 nM 125 I-GalNAc 39 BSA and 25-50 µg membrane protein for the E.histolytica lectin (shaded bars). The data are from saccharide inhibitors added at the maximum concentration tested (2.5 mM; see Table I for comparative IC 50 values derived from concentration versus inhibition curves). Data are grouped according to the parent glycoside (named at the top of each panel). Data are the mean $ SD for triplicate determinations. TFAAH, 6′-Trifluoroacetamidohexyl. 
Effects of multivalent clustering on rat hepatic and E.histolytica lectin binding
Synthetic clustering GalNAc (or Gal) residues on a BSA carrier enhances binding to the mammalian hepatic lectin by several orders of magnitude Lee, 1991) . Our prior report showed a similar enhancement for the E.histolytica lectin (Adler et al., 1995) . In the present study BSA derivatives with different GalNAc densities were tested as inhibitors. For both lectins GalNAc 20 BSA had >1000-fold enhanced binding per GalNAc residue compared to monovalent GalNAc ( Figure 3 , Table II ). Comparison of inhibition by conjugates bearing an average of from 7 to 39 GalNAc residues per BSA molecule revealed only modest differences when expressed per GalNAc residue added ( Figure 3 , Table II , and data not shown). Even GalNAc 7 BSA demonstrated enhanced binding of >550-fold (per GalNAc residue) for both lectins. Note that IC 50 values based on the conjugate molarity (rather than that of its GalNAc residues) are smaller and more dependent on sugar density (GalNAc 7 BSA, IC 50 = 37 nM (rat) and 157 nM (E.histolytica); GalNAc 20 BSA, IC 50 = 5 nM (rat) and 16 nM (E.histolytica)). With the goal of generating selective high affinity inhibitors of the E.histolytica lectin, the synthetic scheme shown in Figure 4 was employed. Since the E.histolytica lectin appeared relatively insensitive to alterations of the N-acyl group as compared to the rat hepatic lectin ( Figure 2 , Table I ), an active ester conjugate was generated by treatment of galactosamine with excess disuccinimidyl adipate. After purification, the N-succinimidyl ester activated N-acyl galactosamine was added to various polyamine carriers to generate the desired polyvalent ligands. Each derivative was purified by size exclusion or ion exchange chromatography, characterized for absence of remaining primary amines, and analyzed by acid hydrolysis followed by qualitative and quantitative galactosamine analysis.
In contrast to the desired goal, each of five linear or clustered polyvalent N-acyl galactosamine derivatives showed greatly enhanced binding to the rat hepatic lectin, but little or no enhancement of binding to the E.histolytica lectin (Figures 5 and 6, Table II ). For the rat hepatic lectin, enhancements due to clustering (per N-acyl galactosamine residue) ranged from a minimum of 40-fold (GalN 4 desmosine) to >1,500-fold (GalN 8 Starburst-G1). In contrast, the greatest enhancement due to clustering for the E.histolytica lectin was only 3-fold (GalN 8 Starburst-G1), and one dendrimer (GalN 4 Starburst-G0) resulted in a 2-fold decrease in binding affinity per N-acyl galactosamine residue. The differential effects on rat hepatic and E.histolytica lectins resulted in strong selectivity of all of the tested polyvalent N-acyl galactosamine derivatives for the rat hepatic lectin. Whereas GalNAc and GalNAc n BSA derivatives demonstrated 3-to 4-fold higher affinities for the rat hepatic lectin compared to the E.histolytica lectin, the polyvalent N-acyl derivatives demonstrated 100-to >2000-fold higher affinities for the rat hepatic lectin (Table II) .
These observations suggested that despite the quantitatively similar enhancement due to clustering on neoglycoproteins, BSA conjugates, which present a heterogeneous mixture of carbohydrate spacings, may provide distinctly different optimal binding clusters for the two lectins. A disparity between neoglycoprotein enhancement and that of lower molecular weight multivalent carbohydrates was reported previously for the rat mannose binding protein (Lee et al., 1992) and for hemagglutination by the E.histolytica lectin (Adler et al., 1995) .
Discussion
Carbohydrate binding specificity by lectins is due to interactions between lectin amino acids and precisely spaced saccharide hydroxyl, N-acyl, and other functional groups . Inhibition studies involving replacement of hydroxyl groups and modification of the N-acetyl group of GalNAc, the highest affinity monosaccharide for binding both the rat hepatic lectin and the E.histolytica lectin (Lee, 1991; Lee and Lee, 1987; Adler et al., 1995) , revealed key differences between the two lectins, the most striking of which was the inability of a 6-deoxy or 6-OCH 3 derivative of a GalNAc glycoside to inhibit E.histolytica lectin binding. For the rat hepatic lectin, the 6-OH can be eliminated or modified with bulky substituents without much effect on affinity (Lee, 1991) . This has allowed photoactivatable and fluorescent reporter groups to be attached to the 6-position of Gal or GalNAc for use as tools for studying the lectin binding site (Rice et al., 1990; Rice and Lee, 1993) . This approach is apparently not feasible for the E.histolytica lectin, since it requires the 6-OH for binding and can not accommodate even a small additional substituent (-CH 3 ). In contrast, the E.histolytica lectin tolerates changes at the N-acetyl group relatively well. In the case of the rat hepatic lectin, a bulky substituent at the 2-position of GalN (e.g., N-benzoyl) lowers affinity substantially, suggesting that the N-acetyl group fits rather snugly into its binding area (Wong et al., 1987) . In contrast, N-benzoyl GalN binds slightly better than GalNAc to the E.histolytica lectin, suggesting that the N-acyl binding area of this lectin is more spacious. Whereas GalN binds the E.histolytica lectin with moderate (mM) affinity, it shows no ability to bind to the mammalian hepatic lectin, suggesting that cationic charge at the 2-position blocks binding to the latter. Although the free amino group gave higher selectivity for the E.histolytica lectin, its affinity was considerably lower than that of the acetylated derivative. These observations led us to test polyvalent N-acyl GalN derivatives as potential selective inhibitors of E.histolytica lectin binding. Contrary to expectations, N-acylated polyvalent derivatives exhibited low affinity for the E.histolytica lectin and high affinity for the rat hepatic lectin (suggesting that a long alkyl group can be tolerated by the rat hepatic lectin binding site much better than an aromatic substituent). We have not determined whether a neoglycoprotein or polyvalent derivative retaining a positive charge at the GalN 2-position can be devised that will exhibit low affinity for the mammalian hepatic lectin, yet retain significant affinity for the E.histolytica lectin.
Clustering of carbohydrates has often been demonstrated to enhance binding affinity to lectins by many orders of magnitude . Studies with C-type lectins have defined two modes of clustering: miniclusters and maxiclusters (Lee, 1994) . These are thought to represent different molecular targeting strategies. Minicluster targeting takes advantage of typical oligosaccharide branching patterns at single glycosylation sites, e.g., binding the tri-or tetraantennary termini of N-linked glycoproteins by the mammalian hepatic lectin. In contrast, maxicluster targeting may have arisen for binding to multivalent structures which are distributed at greater distances, e.g., binding of terminal glycosides on the surface of microbes by the nonimmune defense molecule, serum mannose-binding protein. Interestingly, both the mammalian hepatic lectin and the serum mannose-binding protein display high affinity binding to the appropriate BSA neoglycoproteins (Lee et al., 1992) , which may display both mini-and maxiclusters on the same carrier. In addition to the minicluster effect, the mammalian hepatic lectin manifests enhanced maxicluster affinity due to packing of multiple lectin binding units on the hepatocyte plasma membrane. The concept of mini-and maxiclusters arose to describe the marked differences in the binding of different C-type lectins to multivalent saccharides with distinct spatial arrangements. There is no sharp boundary between mini-and maxiclusters, and this concept continues to evolve in response to new experimental observations.
Whereas the smaller polyvalent inhibitors tested exhibited much less enhancement (43-to 167-fold) for the rat hepatic lectin than did GalNAc-BSA derivatives (>500-fold, Table II), they exhibited nearly no enhancement (<3-fold) for the E.histolytica lectin. It is likely, therefore, that the E.histolytica lectin is a maxicluster targeting lectin. This may reflect the function of the E.histolytica lectin, which has been proposed to engage mucins on the intestinal epithelium during initial attachment and colonization (Chadee et al., 1987; Chadee et al., 1988) . In contrast to the miniclustered termini of N-linked glycoproteins, mucins express multiple short Gal/GalNAc-terminated oligosaccharides distributed on elongated mucin polypeptide backbones (Van Klinken et al., 1995) . In support of this interpretation, linear polyacrylamide polymers derivatized with Gal/GalNAc terminated glycosides demonstrate relatively high affinity binding to the E.histolytica lectin (Adler et al., 1995) . Multivalent nonreducing termini are essential, in that a linear algal polymer of GalNAc (300,000 avg. mol. wt.) failed to inhibit binding of 125 I-GalNAc 39 BSA to either the rat hepatic or E.histolytica lectins at GalNAc residue concentrations of up to 8 mM (data not shown).
GalN 8 Starburst-G1, the largest non-protein inhibitor tested (≈30 Å maximum distance between terminal amines), may mimic the dimensions of GalNAc n BSA (≈80 Å long dimension), so as to manifest a comparable binding enhancement (1550-fold) for the rat hepatic lectin. It was surprising that even this large polyvalent inhibitor did not significantly enhance binding to the E.histolytica lectin. This may indicate that the multiple copies of the E.histolytica lectin present on the parasite surface function relatively independently. Affinity enhancement depends on multivalent lectin presentation, multivalent carbohydrate target presentation, and cooperative interactions of at least one of the partners. Whereas GalNAc n BSA appears to satisfy the latter condition, one can speculate that the interaction of multiple independent E.histolytica lectin molecules with a flexible polyvalent inhibitor falls short of expected enhancement due to a lack of cooperativity on either side of the interaction.
These studies demonstrate a distinct difference in the binding modes of polyvalent ligands by two GalNAc/Gal lectins with similar monosaccharide binding specificities. They further define the fine-structural requirements for the E.histolytica lectin. Together these data may contribute to future efforts to generate a specific and high affinity ligand to target the E.histolytica lectin.
Materials and methods
E.histolytica and rat hepatic lectin binding assays
E.histolytica strain HM1:IMSS trophozoites were grown as reported previously , and membranes prepared as described previously (Adler et al., 1995) . Briefly, amoebae were collected by centrifugation, washed, and sonicated in lysis buffer (10 mM sodium phosphate (pH 8), 2 mM phenylmethylsulfonylfluoride, 5 mM EDTA, 0.1 M 4-(2-aminoethyl)-benzenesulfonylfluoride, and 2 mM p-hydroxymercuribenzoic acid). The resulting membranes were collected by centrifugation, resuspended in 10 mM Hepes buffer pH 7.4 containing 1 mg/ml bovine serum albumin (BSA), and stored on ice until use. Rat liver plasma membranes were prepared by the method of Ray (1970) , and were stored at -20_C until use.
GalNAc 39 BSA was radioiodinated using carrier free Na 125 I and Iodobeads (Pierce Chemical Co., Rockford, IL), and the radiolabeled product was purified by gel filtration chromatography on Sephadex G-25 (Pharmacia Biotech, Piscataway, NJ). The specific activity ranged from 250 to 500 µCi/nmol.
Binding of 125 I-GalNAc 39 BSA to E.histolytica membranes was performed in a 100 µl reaction containing 10 mM Hepes buffer pH 7.4, 50 mM NaCl, 2 mM CaCl 2 , 5 mg/ml BSA, and the indicated concentrations of radioligand, E.histolytica membranes, and saccharide inhibitors. Reactions were incubated with gentle agitation for 4 h at 4_C; then rapidly diluted with 10 mM Hepes buffer (pH 7.4), 10 mM NaCl; and rinsed onto glass fiber filters (presoaked in 10 mM Hepes buffer (pH 7.4), 1 mg/ml BSA) using a Brandel Harvester (Brandel, Gaithersburg, MD). Membranebound radioligand remaining on the glass fiber filters was quantified using a γ-radiation counter. In each experiment, total binding was determined in the absence of inhibitors and background binding in the presence of 25 mM GalNAc or excess ligand (>500 nM GalNAc 31 BSA) as inhibitor. Binding in the presence of inhibitors is expressed as a percentage of specific binding (total -background).
Binding of 125 I-GalNAc 39 BSA to rat hepatic plasma membranes was performed in a 100 µl reaction containing assay buffer (25 mM Tris-HCl buffer pH 7.8, 150 mM NaCl, 20 mM CaCl 2 , 10 mg/ml BSA, 0.02% Triton X-100), and the indicated concentrations of radioligand, rat liver plasma membranes, and saccharide inhibitors. Reactions were incubated with gentle agitation for 90 min at 4_C, then rapidly diluted with assay buffer without BSA and rinsed onto glass fiber filters (presoaked in 25 mM Tris buffer (pH 7.8), 1 mg/ml BSA) using a Brandel Harvester. Specific radioligand binding was determined as described for E.histolytica (above). The concentration of inhibitor required to reduce specific binding by 50% (IC 50 ) was determined graphically.
Inhibitors
The affinities of various monovalent and polyvalent saccharides for the E.histolytica and rat hepatic lectins were determined by inhibition of 125 I-GalNAc 39 BSA binding using the assays described above. D-Galactosamine-HCl and N-acetyl-D-galactosamine were purchased from Pfanstiehl (Waukegan, IL). Preparations of allyl 2-acetamido-2-deoxy-α/β-D-galactopyranoside, 2-acetamido-2-deoxy-4-fluoro-α-D-galactopyranoside, allyl 2-acetamido-2-deoxy-6-O-methyl-β-D-galactopyranoside, 6′-trifluoroacetamidohexyl 2-acetamido-2-deoxy-β-D-galactopyranoside, and N-benzoyl galactosamine have been reported (Wong et al., 1987) . Allyl 3-deoxy-β-N-acetyl-D-galactosamine and allyl 4-deoxy-β-Nacetyl-D-galactosamine were synthesized as described previously (Ichikawa et al., 1990) .
6′-Trifluoroacetamidohexyl 2-acetamido-2,6-di-deoxy-β-Dgalactopyranoside was synthesized essentially according to the method of Siewert and Westphal (1968) . 6′-Trifluoroacetamidohexyl 2-acetamido-2-deoxy-β-D-galactopyranoside was reacted with a two-fold molar excess of tosyl chloride in dry pyridine at room temperature for several days. Thin layer chromatography (TLC) in ethyl acetate/isopropyl alcohol/water (12:2:1) using UV absorption and sulfuric acid char for detection indicated the presence of the desired product (6′-trifluoroacetamidohexyl 2-acetamido-2-deoxy-6-O-tosyl-β-D-galactopyranoside), di-tosylated product, and a small amount of starting material. The desired product was purified by silica gel chromatography using the same solvent. NMR examination showed the correct content of tosyl group, and the position of substitution was confirmed by consumption of sodium periodate due to the presence of vicinal OH groups. The product was per-O-acetylated using acetic anhydride-pyridine (1:1) at room temperature overnight, then processed by evaporation, partition (chloroform-water), and sequential extraction of the chloroform layer with cold solutions of sulfuric acid, sodium bicarbonate, and sodium chloride. The chloroform layer was dried with anhydrous sodium sulfate, filtered, and evaporated, and the residue was dried in a desiccator over concentrated sulfuric acid and sodium hydroxide pellets. 6′-Trifluoroacetamidohexyl 2-acetamido-3,4-di-O-acetyl-2-deoxy-6-O-tosyl-β-D-galactopyranoside was converted to the 6-iodo derivative by refluxing in dimethylformamide in the presence of NaI for 30 min. TLC in toluene-ethyl acetate (1:8) showed one weakly charring product which was devoid of UV absorption and migrated slightly ahead of the starting material. The 6-iodo derivative was purified by silica gel chromatography in toluene/ ethyl acetate (1:8). The NMR spectrum of the product showed the absence of the tosyl group. The replacement of the iodine atom with hydrogen was accomplished by hydrogenation overnight with atmospheric hydrogen in ethyl acetate/ethanol in the presence of sodium acetate and 10% palladium on carbon. The product was purified by silica gel chromatography in toluene/ ethyl acetate (1:8), then de-O-acetylated in 10 mM sodium methoxide in dry methanol (2 h, room temperature). After removal of Na + using Dowex-50 (H + ) resin, the supernatant was evaporated to produce the final product (6′-trifluoroacetamidohexyl 2 acetamido-2,6-di-deoxy-β-D-galactopyranoside). NMR spectroscopy showed the presence of a methyl group at 1.177 ppm (d, 6.57 Hz).
GalNAc n BSA neoglycoproteins (where "n" represents the average number of GalNAc residues attached per BSA molecule) were prepared by the method of Lee et al. (1976) .
An N-hydroxysuccinimide-activated N-acyl derivative of D-galactosamine ( Figure 4A ) was synthesized as follows. Disuccinimidyl adipate (DSA) was prepared by mixing 5 mmol adipic acid, 11 mmol N-hydroxysuccinimide, and 11 mmol 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride in 30 ml ethanol. DSA, which precipitated from solution upon stirring at 4_C for 16 h, was recrystallized from chloroform/ethanol (3:2). To 15.6 mmol purified DSA in 100 ml of dimethylformamide at 4_C was slowly added 30 ml of dimethylformamide containing 3.1 mmol GalN-HCl and 4.7 mmol triethylamine. After 48 h with stirring, solvents were evaporated under vacuum and the residue redissolved in 250 ml of chloroform/ethanol (1:1). Upon partial evaporation and incubation at 4_C excess DSA, which precipitated from the solution, was removed by filtration. The remaining solution was evaporated onto silicic acid beads (Iatrobeads, Iatron Laboratories, Tokyo, Japan), transferred to the top of an Iatrobeads chromatography column, and product eluted with ethyl acetate-ethanol-acetic acid (10:1:1). Elution was monitored by TLC using ethyl acetate/ethanol/acetic acid (5:1:1) as developing solvent. Fractions containing the desired product (some of which precipitated after elution) were combined and solvents evaporated with addition and evaporation of toluene to aid in removal of acetic acid. The resulting residue was redissolved in ethanol and stored at -20_C until use. The desired product migrated as a single spot (R f = 0.27) on TLC (ethyl acetate/ethanol/acetic acid (5:1:1)) which was negative for primary amine (ninhydrin) and positive for carbohydrate (sulfuric acid char) and N-succinimidyl ester (UV absorbance after exposure to ammonia vapor). Hydrolysis of the product in 2 N trifluoracetic acid (2 h, 100_C) followed by Dionex HPLC analysis (Lee, 1990 ) revealed only galactosamine. The yield was 0.98 mmol (32%).
Polyvalent N-acyl galactosamine derivatives were synthesized using four different polyamines ( Figure 4B ): (lys) 5 (Bachem, King of Prussia, PA); desmosine (ICN, Costa Mesa, CA); Starburst (PAMAM) dendrimer, Generation 0 (four primary amines, Aldrich Chem. Co., Milwaukee, WI); and Starburst (PAMAM) dendrimer, Generation 1 (eight primary amines, Aldrich). Starburst dendrimers ( Figure 4B ) are based on an ethylenediaminetetrapropionic acid core, extended via amide linkage to ethylene diamine (generation 0) and higher order branched structures terminating in primary amines (generation 1). To generate each poly-N-acyl galactosamine derivative, the poly-amine was mixed with an excess of the N-succinimidyl-activated N-acyl galactosamine (NSNAG) derivative and triethylamine ( Figure 4A ). After the reaction was complete (as determined by disappearance of primary amine by TLC ninhydrin staining), solvents were evaporated, the residue redissolved, and desired products purified by size-exclusion or ion exchange chromatography. Details of each reaction follow. Lys 5 (15 µmol, 90 µmol primary amine), and 180 µmol each of NSNAG and triethylamine in 63 ml of ethanol were incubated for 16 h, evaporated to dryness, and the residue redissolved in a minimum of 10 mM aqueous triethylammonium bicarbonate (pH 7-8). Chromatography on BioGel P6 (Bio-Rad, Hercules, CA) resulted in resolution of the desired product. Fractions containing polyvalent carbohydrate were combined, lyophilized, and the product stored at -20_C.
Desmosine (5 µmol, 20 µmol primary amine) and 30 µmol each of NSNAG and triethylamine were incubated in 10 ml of ethanol/water (19:1). After 48 h, the reaction was evaporated to a small volume, loaded on a BioGel P2 column (Bio-Rad) and eluted with 10 mM aqueous triethylammonium bicarbonate-ethanol (7:3). Fractions containing macromolecular carbohydrate were combined, lyophilized, and the product stored at -20_C.
Starburst dendrimers (100 µmol primary amine, 20 weight % in methanol) were added to 150 µmol each of NSNAG and triethylamine in 50 ml ethanol. After the reaction was complete (16 h), solvents were evaporated, the residue redissolved in water, and loaded onto a 2 ml column of CM Sepharose (Pharmacia, Uppsala, Sweden). After washing with 10 column volumes of water, the desired products were eluted with 4 column volumes of 1 M aqueous triethylammonium bicarbonate. Eluted products were lyophilized and stored at -20_C.
Aliquots of each polyvalent N-acyl galactosamine derivative were hydrolyzed for 2 h in 1 M trifluoracetic acid and released galactosamine quantified by Dionex HPLC carbohydrate analysis with pulsed amperometric detection (Lee, 1990) .
